In a study aiming to determine changes of stromal proteins in breast cancer following neoadjuvant chemotherapy, TN-C was identified as a molecule being important for conferring cancer cell resistance to doxorubicin- and docetaxel-based neoadjuvant chemotherapy by activating the integrinβ1/mTOR pathway (136). The gene discussed is TNC; the disease is cancer.